Process Research & Development

We support the selection and development of optimum synthetic routes for drug substance manufacturing, also known as API (Active Pharmaceutical Ingredient) manufacturing.

We combine rapid route selection with the implementation of innovative technological solutions to produce the shortest, most efficient and most scalable pathway to a drug substance. Our focus is on process velocity and economy, product purity, process scalability, and safety. The drug substance can then be scaled to multi-kilogram quantities to support direct client supply, or as part of an integrated in-house drug substance/drug product package to support clinical trials or full-scale commercialization programs.

Quotient Sciences' philosophy targets optimal velocity for drug substance delivery, to ensure rapid drug substance supply for urgent clinical trial needs while enhancing process efficiency and robustness to lower costs and generate higher purity. Our work also involves defining the best route for product manufacturing scalability.